Joint Health, Anti-Inflammatory, and Vitamin C

How rosehip's unique galactolipid compound reduces joint pain in osteoarthritis and supports cardiovascular and metabolic health

Rosehip is the fruit of the rose plant — the small, round seed pod left behind after the flower drops its petals. Long used in traditional European and Turkish medicine, rosehip has now earned a solid evidence base for reducing joint pain in osteoarthritis, with a 2008 meta-analysis of three randomized controlled trials finding that patients taking rosehip were twice as likely to respond to treatment compared to placebo [2]. The benefit comes largely from a unique anti-inflammatory compound called GOPO — a galactolipid found only in the seed and shell of Rosa canina — rather than from vitamin C alone. Rosehip is also one of the most concentrated food sources of vitamin C on the planet, with roughly 20 times more per gram than orange juice [6].

How Rosehip Works: The GOPO Galactolipid

For decades, rosehip's health benefits were assumed to come entirely from its high vitamin C content. Then in 2003, researchers isolated a novel compound from Rosa canina seeds and shells: a glycoside of mono- and diglycerol (GLPG) — now marketed as GOPO [3]. This galactolipid is structurally unique to rosehip and has no equivalent in other commonly consumed plants.

GOPO's primary mechanism is the inhibition of neutrophil chemotaxis — it prevents neutrophils (the immune cells responsible for the early stages of inflammation) from migrating to inflamed tissue. In healthy physiology, neutrophils are recruited to a site of injury or pathogen invasion. But in chronic inflammatory conditions like osteoarthritis, excessive neutrophil activity perpetuates the cycle of cartilage degradation. GOPO appears to dampen this cycle without broadly suppressing the immune system [3].

Further research has shown that rosehip powder and its galactolipid components also [4]:

Suppress matrix metalloproteinases (MMPs) — enzymes that break down joint cartilage
Reduce nitric oxide and prostaglandin E2 secretion in inflamed macrophages
Decrease levels of pro-inflammatory cytokines and chemokines in chondrocyte (cartilage cell) models

This multi-target anti-inflammatory action explains why rosehip outperforms a simple vitamin C supplement for joint conditions.

Joint Pain and Osteoarthritis

The clinical evidence for rosehip in osteoarthritis is among the most rigorous available for any herbal supplement. The landmark 2005 RCT enrolled 94 adults with hip or knee osteoarthritis in a three-month, double-blind, placebo-controlled trial [1]. Participants taking 5g/day of standardized rosehip powder (containing seeds and shells of Rosa canina) showed:

Significant reduction in WOMAC pain scores within 3 weeks of starting
Reduced use of rescue pain medications
Improvements in stiffness and physical function scores at 3 months compared to placebo

A 2008 meta-analysis then pooled data from three such RCTs (n=287 total participants) and found that rosehip powder more than doubled the odds of responding to treatment compared to placebo (OR = 2.19, 95% CI 1.39–3.45, p = 0.0009) [2]. The Number Needed to Treat was 6 — meaning for every 6 people who take rosehip instead of placebo, one extra person experiences meaningful pain relief. The effect size for pain reduction was 0.37, which is comparable to low-dose ibuprofen in similar populations.

Standard dosing in the clinical trials was 5g/day of standardized rosehip seed-and-shell powder. Results typically emerge within 3–4 weeks of consistent use. The proprietary extract LitoZin (used in the trials) is the best-studied form, but standardized rosehip seed powder from other sources appears to share the same active compounds when properly processed.

Vitamin C Content and Antioxidant Properties

Fresh rosehip fruit contains approximately 400–800 mg of vitamin C per 100g — compared to roughly 50 mg per 100g in orange juice [6]. This positions it among the highest natural sources of ascorbic acid available. However, processing matters: heat and drying can degrade vitamin C substantially. Cold-processed or freeze-dried rosehip powder retains far more vitamin C than products dried at high temperatures.

Beyond vitamin C, rosehip contains [6]:

Carotenoids: Beta-carotene, lycopene, and zeaxanthin — potent antioxidants
Polyphenols: Ellagic acid, quercetin, and kaempferol
Organic acids: Malic acid and citric acid
Tocopherols: Vitamin E in the seed oil

This combination gives rosehip broad antioxidant activity. It scavenges reactive oxygen species, reduces oxidative stress markers in cell models, and protects lipids from peroxidation. These properties may contribute to its cardiovascular benefits beyond joint health.

Cardiovascular and Metabolic Effects

A 2012 randomized, double-blind, crossover trial enrolled 31 obese adults who consumed a daily 40g rosehip powder drink for 6 weeks [5]. Compared to control:

Systolic blood pressure fell by 3.4%
Total cholesterol decreased by 4.9%
LDL cholesterol fell by 6.0%
A composite cardiovascular risk score improved by 17%

These effects were observed without any dietary or lifestyle changes, suggesting rosehip's bioactive compounds exert direct effects on lipid metabolism and vascular tone. The trigonelline and polyphenol content may play a role, alongside the antioxidant protection of LDL from oxidation.

How to Use Rosehip

Powder: The form used in most clinical trials. Add 5g (about 1 heaped teaspoon) to smoothies, oatmeal, or yogurt. Choose cold-processed or freeze-dried powder to preserve vitamin C and GOPO content.

Capsules: Standardized extracts of 2.5g per capsule are widely available; 2 capsules daily matches trial dosing.

Tea: Dried rosehip makes a pleasant tart tea rich in polyphenols, though vitamin C content is reduced by hot water. Steep at lower temperatures (below 80°C) if preserving ascorbic acid is a priority.

Oil: Rosehip seed oil is pressed from the seeds and is used topically for skin. It contains vitamins A and C and is widely used for scar healing and skin moisture; this is a separate application from the internal joint/anti-inflammatory evidence.

Cross-reference: See our Boswellia page and MSM page for other well-evidenced natural joint support options.

Evidence Review

Winther et al. (2005) — Randomized, Double-Blind, Placebo-Controlled Trial, Scandinavian Journal of Rheumatology

This was the pivotal clinical trial establishing rosehip's efficacy in osteoarthritis. Ninety-four patients with clinically verified hip or knee OA were randomized to receive 5g/day of standardized Rosa canina seed-and-shell powder (LitoZin) or matched placebo for three months. The primary outcome was the Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale, a validated and widely accepted measure for OA trials. Statistically significant pain score reductions were observed within 3 weeks in the rosehip group, and the treatment group used significantly fewer rescue analgesics (NSAIDs, acetaminophen) over the trial period. At 3 months, stiffness and physical function subscores also improved significantly. No serious adverse events were reported. Limitations include the relatively small sample size and single-center design [1].

Christensen et al. (2008) — Meta-Analysis, Osteoarthritis and Cartilage

This meta-analysis pooled individual participant data from three RCTs of rosehip powder in OA, including the Winther trial, for a combined sample of 287 participants. The primary analysis examined the odds ratio for treatment response (defined as meaningful patient-reported improvement). Patients randomized to rosehip were more than twice as likely to respond compared to placebo (OR = 2.19, 95% CI 1.39–3.45, p = 0.0009). The Number Needed to Treat was 6. Secondary analyses found a standardized mean difference of 0.37 for pain reduction — comparable to effect sizes reported for low-dose ibuprofen and other OTC NSAIDs in similar OA populations, but without the gastrointestinal side effects associated with NSAID use. The authors concluded that rosehip powder is an effective and safe intervention for OA pain and recommended it as a first-line option for patients who cannot tolerate or wish to avoid NSAIDs [2].

Larsen et al. (2003) — Mechanistic Study, Journal of Natural Products

This foundational study first identified and characterized the anti-inflammatory galactolipid from Rosa canina seeds and shells — the compound now known as GOPO. The researchers fractionated Rosa canina extracts and isolated the active anti-inflammatory component using bioassay-guided fractionation, then determined its structure by NMR and mass spectrometry. GOPO was identified as a glycoside of mono- and diglycerol. In vitro testing against human peripheral blood neutrophils demonstrated potent inhibition of chemotaxis (cell migration toward an inflammatory signal) at concentrations achievable in vivo, with no cytotoxic effects on the neutrophils at active concentrations. This study established the mechanistic rationale for rosehip's anti-inflammatory action and explained why seed-and-shell preparations are more effective than rosehip fruit pulp alone [3].

Schwager et al. (2011) — Cell and Tissue Study, BMC Complementary and Alternative Medicine

This study extended the mechanistic understanding of rosehip's anti-inflammatory effects to cartilage-relevant cell types. Using macrophage, leukocyte, and chondrocyte models stimulated with lipopolysaccharide or IL-1β, the researchers found that rosehip powder and isolated galactolipid fractions suppressed: nitric oxide production, prostaglandin E2 secretion, matrix metalloproteinase expression (MMP-1, MMP-3, MMP-13), and multiple pro-inflammatory cytokines and chemokines (IL-6, IL-8, CCL2). The suppression of MMPs is particularly relevant to OA, as these enzymes are responsible for the degradation of cartilage collagen and proteoglycans. The anti-inflammatory effects were dose-dependent and reproducible across cell types. These findings help explain both the joint-protective and broader anti-inflammatory effects observed in clinical trials [4].

Andersson et al. (2012) — Randomized Double-Blind Crossover Trial, European Journal of Clinical Nutrition

This 6-week crossover trial enrolled 31 obese participants (BMI 25–35) who consumed either a rosehip powder drink (40g rosehip powder in water) or a matched control drink daily. Fasting lipids, blood pressure, and calculated cardiovascular risk scores were measured at baseline and end of each intervention period. Systolic blood pressure fell 3.4% with rosehip versus control (p < 0.05). Total cholesterol declined 4.9% and LDL-cholesterol 6.0% (both p < 0.05). A composite cardiovascular risk score using the Framingham algorithm improved 17% with rosehip relative to control. Body weight did not change significantly, indicating the effects were not mediated by weight loss. The crossover design (with 2-week washout between arms) allows participants to serve as their own controls, increasing statistical power for a modest sample size. Limitations include the relatively short duration and the focus on intermediate risk markers rather than hard cardiovascular endpoints [5].

Mármol et al. (2017) — Comprehensive Review, International Journal of Molecular Sciences

This review surveyed the ethnobotanical uses, phytochemical composition, and biological activities of Rosa canina across European and Middle Eastern traditional medicine. The vitamin C content of fresh rosehip (typically 400–800 mg/100g) is documented as one of the highest among commonly consumed plant foods, though the review also notes significant variation by cultivar, ripeness, and drying method — with high-temperature drying able to reduce ascorbic acid content by 50–90%. The review catalogs additional bioactive compounds (carotenoids, flavonoids, tocopherols, organic acids) and summarizes evidence for antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory activities. The review supports the use of cold-processing methods to preserve the full phytochemical profile and underscores that rosehip's health properties cannot be attributed to vitamin C alone [6].

Evidence Summary

Rosehip stands out in the herbal medicine evidence landscape for having both a plausible and well-characterized mechanism (the GOPO galactolipid) and multiple randomized controlled trials and a meta-analysis supporting its efficacy in osteoarthritis. The meta-analytic evidence (OR = 2.19, NNT = 6) places rosehip among the better-evidenced natural supplements for joint pain — the effect size is clinically meaningful and comparable to low-dose OTC analgesics. Cardiovascular evidence from one crossover trial is promising but should be replicated in larger studies. The vitamin C content and antioxidant profile offer additional mechanistic rationale for broader health benefits. For people with osteoarthritis or looking for a safe, non-NSAID anti-inflammatory option, the evidence for rosehip seed-and-shell powder is genuinely robust by herbal supplement standards.

References

A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trialWinther K, Apel K, Thamsborg G. Scandinavian Journal of Rheumatology, 2005. PubMed 16195164 →
Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? -- a meta-analysis of randomized controlled trialsChristensen R, Bartels EM, Altman RD, Astrup A, Bliddal H. Osteoarthritis and Cartilage, 2008. PubMed 18407528 →
An antiinflammatory galactolipid from rose hip (Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitroLarsen E, Kharazmi A, Christensen LP, Christensen SB. Journal of Natural Products, 2003. PubMed 12880322 →
Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expressionSchwager J, Hoeller U, Wolfram S, Richard N. BMC Complementary and Alternative Medicine, 2011. PubMed 22051322 →
Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese personsAndersson U, Berger K, Hogberg A, Landin-Olsson M, Holm C. European Journal of Clinical Nutrition, 2012. PubMed 22166897 →
Rosa canina — Rose Hip Ethnomedicinal Group of DiversityMarmol I, Sanchez-de-Diego C, Dieste AP, Cerrada E, Rodriguez Yoldi MJ. International Journal of Molecular Sciences, 2017. PubMed 28587101 →